Buys
Open market- Shares
- Avg price
- Total value
John Kenneth Jenkins - Director at Corbus Pharmaceuticals Holdings, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- CRBP on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for John Kenneth Jenkins in Corbus Pharmaceuticals Holdings, Inc.
Sells
Open market- Shares
- -4,800
- Avg price
- $7.91
- Total value
- -$37,986
Net
Past year- Shares
- -4,800
- Share %
- -100%
- Total value
- -$37,986
Reported holdings for John Kenneth Jenkins in Corbus Pharmaceuticals Holdings, Inc.
Form 4 holding
Director
Corbus Pharmaceuticals Holdings, Inc.
- Security class
- Common Stock, par value $0.0001 per share
- Shares / value
- 2,816
- Estimated value
- $84,480
- Report date
- 30 May 2024
- Price
- $30.00
- Ownership
- Direct
Form 4 holding
Director
Corbus Pharmaceuticals Holdings, Inc.
- Security class
- Common Stock, par value $0.0001 per share
- Shares / value
- 3,833
- Estimated value
- $30,333
- Report date
- 10 Jun 2026
- Price
- $7.91
- Ownership
- Direct
Form 4 holding
Director
Corbus Pharmaceuticals Holdings, Inc.
- Security class
- Stock options (right to buy)
- Shares / value
- 12,300
- Estimated value
- Report date
- 19 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for John Kenneth Jenkins in Corbus Pharmaceuticals Holdings, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.